Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?

J Med Virol. 2021 Jul;93(7):4049-4053. doi: 10.1002/jmv.26922. Epub 2021 Mar 25.

Abstract

Coronavirus disease 2019 (COVID-19) vaccination campaign in Italy has started with a huge perplexity about vaccine efficacy, vaccine-borne adverse effects and vaccine clinical trial studies. In this commentary I tried to elucidate these issues, which represent a fundamental topic to be thoroughly addressed in COVID-19 pandemic.

Keywords: administrative law; coronavirus; political science; public policy; social science; virus classification.

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Anaphylaxis / etiology
  • BNT162 Vaccine
  • COVID-19 / epidemiology
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines* / adverse effects
  • COVID-19 Vaccines* / immunology
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Italy / epidemiology
  • Liposomes / adverse effects
  • Mass Vaccination
  • Nanoparticles / adverse effects
  • Pandemics / prevention & control
  • Polyethylene Glycols / adverse effects
  • Vaccination Refusal*
  • Vaccines, Synthetic* / adverse effects
  • Vaccines, Synthetic* / immunology
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Lipid Nanoparticles
  • Liposomes
  • Vaccines, Synthetic
  • Polyethylene Glycols
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine